Načítá se...
Clinical spectrum and prognostic value of TP53 mutations in circulating tumor DNA from breast cancer patients in China
BACKGROUND: TP53 mutations are common in breast cancer. There is currently no large‐scale cohort study to investigate the TP53 landscape in breast cancer patients from China. The predictive value of TP53 mutations for the efficacy of human epidermal growth factor receptor 2 (HER2)‐targeted therapy i...
Uloženo v:
| Vydáno v: | Cancer Commun (Lond) |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7307233/ https://ncbi.nlm.nih.gov/pubmed/32436611 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cac2.12032 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|